Product Details
Research-grade peptides with clear specifications, COA-backed quality verification, and Fahrenheit storage guidance for laboratory use.
GLP-3RT -60MG
Overview
This peptide is a triple-receptor agonist, meaning it simultaneously activates three key metabolic pathways.
$200.00
Out of stock
Share this item
Description
This peptide is a triple-receptor agonist, meaning it simultaneously activates three key metabolic pathways. First, it targets the GLP-1 receptor, which is known to enhance insulin secretion, reduce appetite, and slow gastric emptying. Second, it activates the GIP receptor, which also supports insulin release and fat metabolism. Finally, it engages the glucagon receptor, which boosts energy expenditure by increasing fat breakdown. Together, these coordinated actions promote weight loss by reducing food intake, improving glucose control, and boosting metabolism, making it a powerful modulator of body weight and metabolic health.
GLP-3RT Triple Receptor Agonist Research Peptide Research Details
GLP-3RT is positioned as a triple-receptor research analog. The scientific approach is based on incretin-triagonist literature where GLP-1R, GIPR, and glucagon-receptor signaling are combined to study appetite, insulin secretion, energy expenditure, and metabolic pathway integration in experimental models.
99%+ target purity or lot-specific COA value
Triple agonist analog; verify exact sequence by COA
Lyophilized research material unless otherwise specified by COA
Research use only
Research Background
Research peptide conceptually aligned with GLP-1/GIP/glucagon receptor tri-agonism for incretin and metabolic-pathway studies. Key OneBio research contexts include incretin receptor assays, metabolic signaling, glp-1r/gipr/glucagon receptor comparison, and peptide analog profiling.
Specifications
| Compound | GLP-3RT Triple Receptor Agonist Research Peptide |
| SKU / Product | glp-3rt |
| Molecular Weight | Lot-specific |
| Formula / Classification | Lot-specific |
| Database / Identity Note | Research analog; verify by COA |
| Storage | -4°F long-term; 35-46°F short-term refrigerated; 39°F after reconstitution for up to 30 days when appropriate for the research protocol |
Quality Verification
Each batch should be reviewed against its Certificate of Analysis, including identity confirmation, purity method, mass/sequence or component confirmation, appearance, and lot-specific handling notes. Blend products should be checked against component-ratio documentation where available.
Laboratory Preparation
Prepare only inside a qualified laboratory using validated solvent choice, concentration, sterility, and storage protocols. For lyophilized peptides, use sterile deionized water or bacteriostatic water when appropriate for the research protocol, mix gently, maintain cold-chain handling, and avoid repeated freeze-thaw cycles.
Product-Specific Q&A
What is GLP-3RT Triple Receptor Agonist Research Peptide used for in research?
GLP-3RT Triple Receptor Agonist Research Peptide is used as a research material for incretin receptor assays, metabolic signaling, glp-1r/gipr/glucagon receptor comparison, and peptide analog profiling. It is not offered for diagnostic, therapeutic, clinical, veterinary, or human-use applications.
What mechanism is most relevant for GLP-3RT Triple Receptor Agonist Research Peptide?
Research peptide conceptually aligned with GLP-1/GIP/glucagon receptor tri-agonism for incretin and metabolic-pathway studies.
How should GLP-3RT Triple Receptor Agonist Research Peptide identity and purity be verified?
Use the lot-specific Certificate of Analysis to confirm identity, purity, mass/sequence or component profile, and any method-specific data such as LC-MS/HPLC. Technical values on this page are research references and should be checked against the delivered lot.
What storage conditions apply to GLP-3RT Triple Receptor Agonist Research Peptide?
-4°F long-term; 35-46°F short-term refrigerated; 39°F after reconstitution for up to 30 days when appropriate for the research protocol. Keep sealed, dry, protected from light, and avoid repeated freeze-thaw cycles after preparation.
References
- PMID 36372278: Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment. Pharmacological research 2022.
- PMID 37562748: Incretins (GLP-1 receptor agonists and dual/triple agonists) and the liver. Journal of hepatology 2023.
- PMID 40022548: The promise of glucagon-like peptide 1 receptor agonists (GLP-1RA) for the treatment of obesity: a look at phase 2 and 3 pipelines. Expert opinion on investigational drugs 2025.
Expanded Product Information
PeptideTech-style product tools added beneath the existing OneBio product layout: tabs, specifications, COA guidance, shipping/storage information, stock-solution guidance, verification notes, and FAQ.
| Product | Current product |
|---|---|
| Form | Lyophilized research material unless otherwise stated on the product label. |
| Purity / Identity | See product listing and available COA/batch documentation. |
| Storage | Long-term freezer storage around -4°F. Short-term refrigerated storage 35–46°F. Reconstituted materials should be handled under validated laboratory protocols. |
| Use Standard | Research-use only; not for human or animal administration. |
Third-party verification: Review the available Certificate of Analysis and batch documentation before use. Verify identity, purity, appearance, and lot-specific details against your lab requirements.
Are these products for research use only?
Yes. OneBio Research products are sold strictly for laboratory research and analytical testing.
Where do I find storage guidance?
Use the product label, COA, and the storage tab above. Long-term freezer storage is commonly referenced around -4°F; refrigerated short-term storage is 35–46°F.
Can I request documentation?
Yes. Use the COA/documentation request link or contact OneBio Research with the product and lot details.
Reviews
There are no reviews yet.